Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment with selective serotonin reuptake inhibitors during pregnancy: deceleration of weight gain because of depression or drug?

× No keyword cloud information.

16 in total

1. Risk-benefit decision making for treatment of depression during pregnancy.

Authors: K L Wisner; D A Zarin; E S Holmboe; P S Appelbaum; A J Gelenberg; H L Leonard; E Frank
Journal: Am J Psychiatry Date: 2000-12 Impact factor: 18.112

2. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study.

Authors: Irena Nulman; Joanne Rovet; Donna E Stewart; Jacob Wolpin; Pia Pace-Asciak; Samar Shuhaiber; Gideon Koren
Journal: Am J Psychiatry Date: 2002-11 Impact factor: 18.112

3. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.

Authors: N Sussman; D L Ginsberg; J Bikoff
Journal: J Clin Psychiatry Date: 2001-04 Impact factor: 4.384

Review 4. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.

Authors: Eydie L Moses-Kolko; Debra Bogen; James Perel; Amy Bregar; Kathleen Uhl; Bob Levin; Katherine L Wisner
Journal: JAMA Date: 2005-05-18 Impact factor: 56.272

5. Outcomes of prenatal antidepressant exposure.

Authors: Gregory E Simon; Michael L Cunningham; Robert L Davis
Journal: Am J Psychiatry Date: 2002-12 Impact factor: 18.112

Review 6. Pharmacologic treatment of depression during pregnancy.

Authors: K L Wisner; A J Gelenberg; H Leonard; D Zarin; E Frank
Journal: JAMA Date: 1999-10-06 Impact factor: 56.272

7. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations.

Authors: Kari Laine; Tuija Heikkinen; Ulla Ekblad; Pentti Kero
Journal: Arch Gen Psychiatry Date: 2003-07

Treatment with selective serotonin reuptake inhibitors during pregnancy: deceleration of weight gain because of depression or drug?

1. Risk-benefit decision making for treatment of depression during pregnancy.

2. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study.

3. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.

Review 4. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.

5. Outcomes of prenatal antidepressant exposure.

Review 6. Pharmacologic treatment of depression during pregnancy.

7. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations.

8. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac)

9. Birth outcomes in pregnant women taking fluoxetine.

10. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants.

1. Identification of postpartum depression.